Chitkara Open Access Journals - Blog

Histone Deacetylase Inhibitors As Potential Therapeutic Agents For Various Disorders

Epigenetic modification acetylation or deacetylation of histone considered as an important element in various disorders. Histone acetyltransferases (HATs) and histone deacetylases (HDACs) are the enzymes which catalyse the acetylation and deacetylation of histone respectively. It helps in regulating the condensation of chromatin and transcription of genes.

Author(s):

Kajal Thapa, Savir Kumar, Anurag Sharma, Sandeep Arora, Amarjot Kaur Grewal and Thakur Gurjeet Singh, Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab-140401

Keywords:

Epigenetic, Histone, Acetylation, Deacetylation, Lysine, Histone deacetylases inhibitors

URL:

https://jptrm.chitkara.edu.in/index.php/jptrm/article/view/19/14

References:

Belvedere, S., Witter, D.J., Yan, J., Secrist, J.P., Richon, V. and Miller, T.A., (2007). Aminosuberoyl hydroxamic acids (ASHAs): a potent new class of HDAC inhibitors. Bioorganic & medicinal chemistry letters, 17(14), 3969–3971. https://doi.org/10.1016/j.bmcl.2007.04.089

Cha, M.K., Suh, K.H. and Kim, I.H., (2009). Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma. Journal of Experimental & Clinical Cancer Research, 28(1), 93. https://doi.org/10.1186/1756-9966-28-93

Chen, J., (2016). The cell-cycle arrest and apoptotic functions of p53 in tumour initiation and progression. Cold Spring Harbor perspectives in medicine, doi: 10.1101/cshperspect.a026104. https://doi.org/10.1101/cshperspect.a026104

Georgescu, M.M., (2010). PTEN tumour suppressor network in PI3K-Akt pathway control. Genes & cancer, 1(12), 1170–1177. https://doi.org/10.1177/1947601911407325

Glass, C.K. and Rosenfeld, M.G., (2000). The coregulator exchange in transcriptional functions of nuclear receptors. Genes & development, 14(2), 121–141.

Glass, C.K. and Rosenfeld, M.G., 2000. The coregulator exchange in transcriptional functions of nuclear receptors. Genes & development, 14(2), 121–141.

Gräff, J. and Tsai, L.H., (2013). The potential of HDAC inhibitors as cognitive enhancers. Annual review of pharmacology and toxicology, 53, 311–330. https://doi.org/10.1146/annurev-pharmtox-011112-140216

Green, K.N., Steffan, J.S., Martinez-Coria, H., Sun, X., Schreiber, S.S., Thompson, L.M. and LaFerla, F.M., (2008). Nicotinamide restores cognition in Alzheimer’s disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau. Journal of Neuroscience, 28(45), 11500–11510.

https://doi.org/10.1523/JNEUROSCI.3203-08.2008

Gregersen, R., Lambertsen, K. and Finsen, B., (2000). Microglia and macrophages are the major source of tumour necrosis factor in permanent middle cerebral artery occlusion in mice. Journal of Cerebral Blood Flow & Metabolism, 20(1), 53–65. https://doi.org/10.1097/00004647-200001000-00009

Grozinger, C.M., Chao, E.D., Blackwell, H.E., Moazed, D. and Schreiber, S.L., (2001). Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening. Journal of Biological Chemistry, 276(42), 38837–38843. https://doi.org/10.1074/jbc.M106779200